78 related articles for article (PubMed ID: 20423879)
21. Antimonocyte chemoattractant protein-1 gene therapy reduces experimental in-stent restenosis in hypercholesterolemic rabbits and monkeys.
Ohtani K; Usui M; Nakano K; Kohjimoto Y; Kitajima S; Hirouchi Y; Li XH; Kitamoto S; Takeshita A; Egashira K
Gene Ther; 2004 Aug; 11(16):1273-82. PubMed ID: 15175640
[TBL] [Abstract][Full Text] [Related]
22. Impact of pathogen burden on in-stent restenosis in patients after coronary stent implantation.
Niu YH; Ge JB; Xu CF; Shi JH; Jin XJ; Qian JY; Zou YZ
Chin Med J (Engl); 2005 Nov; 118(21):1786-90. PubMed ID: 16336815
[TBL] [Abstract][Full Text] [Related]
23. [Comment to article Acute coronary syndrome - a frequent clinical manifestation of bare metal in-stent restenosis].
Bryniarski L
Kardiol Pol; 2010 Jun; 68(6):646-7. PubMed ID: 20806193
[No Abstract] [Full Text] [Related]
24. Very late bare metal stent thrombosis: The role of restenosis.
Sengül C; Erdoğan T; Dindar I
Turk Kardiyol Dern Ars; 2010 Jun; 38(4):282-4. PubMed ID: 20935438
[TBL] [Abstract][Full Text] [Related]
25. Endothelial vasomotor dysfunction in the brachial artery is associated with late in-stent coronary restenosis.
Kitta Y; Nakamura T; Kodama Y; Takano H; Umetani K; Fujioka D; Saito Y; Kawabata K; Obata JE; Ichigi Y; Mende A; Kugiyama K
J Am Coll Cardiol; 2005 Aug; 46(4):648-55. PubMed ID: 16098430
[TBL] [Abstract][Full Text] [Related]
26. Successful balloon angioplasty of in-stent restenosis of left internal mammary artery.
Chandrasekar B; deGuise P; Doucet S
J Invasive Cardiol; 1999 Jul; 11(7):447-9. PubMed ID: 10745571
[TBL] [Abstract][Full Text] [Related]
27. Inflammation as a mechanism and therapeutic target for in-stent restenosis.
Drachman DE; Simon DI
Curr Atheroscler Rep; 2005 Feb; 7(1):44-9. PubMed ID: 15683602
[TBL] [Abstract][Full Text] [Related]
28. Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents.
Ajani AE; Yan BP; Clark DJ; Eccleston D; Walton A; Lew R; Meehan A; Brennan A; Reid C; Duffy SJ;
Heart Lung Circ; 2007 Aug; 16(4):269-73. PubMed ID: 17419097
[TBL] [Abstract][Full Text] [Related]
29. [Inflammatory response after coronary angioplasty - mechanisms and significance].
Koziński M; Kubica J
Kardiol Pol; 2006 Jul; 64(7):771-4; author reply 775. PubMed ID: 16886140
[No Abstract] [Full Text] [Related]
30. [Balloon angioplasty for the treatment of the drug-eluting stent restenosis in a patient with multivessel coronary artery disease and muscular bridge].
Pawłowski T; Kulawik T; Rzezak J
Kardiol Pol; 2008 Nov; 66(11):1229-31; discussion 1232. PubMed ID: 19105104
[No Abstract] [Full Text] [Related]
31. Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-eluting stent implantation.
Iaccarino D; Politi L; Rossi R; Sgura F; Monopoli D; Modena MG; Sangiorgi GM
J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):536-43. PubMed ID: 20090547
[TBL] [Abstract][Full Text] [Related]
32. Hepatocyte growth factor plays a critical role in the regulation of cytokine production and induction of endothelial progenitor cell mobilization: a pilot gene therapy study in patients with coronary heart disease.
Yang ZJ; Xu SL; Chen B; Zhang SL; Zhang YL; Wei W; Ma DC; Wang LS; Zhu TB; Li CJ; Wang H; Cao KJ; Gao W; Huang J; Ma WZ; Wu ZZ
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):790-6. PubMed ID: 19215239
[TBL] [Abstract][Full Text] [Related]
33. The effect of senescence of endothelial progenitor cells on in-stent restenosis in patients undergoing coronary stenting.
Matsuo Y; Imanishi T; Hayashi Y; Tomobuchi Y; Kubo T; Hano T; Akasaka T
Intern Med; 2006; 45(9):581-7. PubMed ID: 16755088
[TBL] [Abstract][Full Text] [Related]
34. Microscopic and histological analysis of the processes occurring in the aperture and wall of a coronary vessel after stent implantation.
Grygier D; Kuropka P; Dudziński W
Acta Bioeng Biomech; 2008; 10(3):55-60. PubMed ID: 19152474
[TBL] [Abstract][Full Text] [Related]
35. Interleukin 6 but not interleukin 10 is associated with restenosis after coronary stenting.
Ezhov MV; Sumarokov AB; Raimbekova IR; Masenko VP; Naumov VG
Atherosclerosis; 2003 Jul; 169(1):193-4. PubMed ID: 12860267
[No Abstract] [Full Text] [Related]
36. Chemokines on the rise : mcp-1 and restenosis.
Schmidt AM; Stern DM
Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):297-9. PubMed ID: 11231906
[No Abstract] [Full Text] [Related]
37. Monocyte chemoattractant protein-1 and coronary artery disease.
Ikeda U; Matsui K; Murakami Y; Shimada K
Clin Cardiol; 2002 Apr; 25(4):143-7. PubMed ID: 12000070
[TBL] [Abstract][Full Text] [Related]
38. Common polymorphism +45T/G in adiponectin gene as potential modulator of in-stent restenosis development.
Bienertova-Vasku J; Bienert P; Hlinomaz O; Vasku A
Int J Cardiol; 2010 Nov; 145(2):351. PubMed ID: 20045207
[TBL] [Abstract][Full Text] [Related]
39. Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty.
Ikeda U; Shimada K
Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):1090-1. PubMed ID: 11397725
[No Abstract] [Full Text] [Related]
40. The monocyte: the key in the lock to reduce stent hyperplasia?
Colombo A; Sangiorgi G
J Am Coll Cardiol; 2004 Jan; 43(1):24-6. PubMed ID: 14715177
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
